Ionis Pharmaceuticals, Inc. Receivables, Long-term Contracts or Programs
Ionis Pharmaceuticals, Inc. (IONS) had Receivables, Long-term Contracts or Programs of $62.95 million as of 2017-12-31, per its 10-K filed 2018-02-28.
Discontinued › Balance Sheet › Assets
us-gaap:ReceivablesLongTermContractsOrPrograms · last filed 2018-02-28
- 2017-12-31: Receivables, Long-term Contracts or Programs $62.95M.
- 2017-09-30: Receivables, Long-term Contracts or Programs $42.92M.
- 2017-06-30: Receivables, Long-term Contracts or Programs $50.62M.
- 2017-03-31: Receivables, Long-term Contracts or Programs $69.36M.
| Period end | Receivables, Long-term Contracts or Programs |
|---|---|
| 2017-12-31 | $62.95M 10-K · filed 2018-02-28 |
| 2017-09-30 | $42.92M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $50.62M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $69.36M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $108.04M 10-K · filed 2018-02-28 |
| 2016-09-30 | $8.54M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $746.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $16.48M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $11.36M 10-K · filed 2017-03-01 |
| 2015-09-30 | $1.83M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $3.26M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $26.93M 10-Q · filed 2015-05-05 |
| 2014-12-31 | $3.90M 10-K · filed 2016-02-26 |
| 2014-09-30 | $26.31M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $41.94M 10-Q · filed 2014-08-04 |
| 2014-03-31 | $9.82M 10-Q · filed 2014-05-06 |
| 2013-12-31 | $11.10M 10-K · filed 2015-03-02 |
| 2013-09-30 | $12.64M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $2.02M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $1.17M 10-Q · filed 2013-05-07 |
| 2012-12-31 | $522.00K 10-K · filed 2014-03-03 |
| 2012-09-30 | $3.48M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $1.56M 10-Q · filed 2012-08-06 |
| 2012-03-31 | $1.38M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $6.92M 10-K · filed 2013-02-28 |
| 2011-09-30 | $1.86M 10-Q · filed 2011-11-08 |
| 2011-06-30 | $5.67M 10-Q · filed 2011-08-08 |
| 2011-03-31 | $591.00K 10-Q · filed 2011-05-06 |
| 2010-12-31 | $1.24M 10-K · filed 2012-02-29 |
| 2010-09-30 | $1.34M 10-Q · filed 2010-11-05 |
| 2010-06-30 | $5.04M 10-Q · filed 2010-08-09 |
| 2009-12-31 | $10.90M 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |